Publications by authors named "M Kamst"

Claim this Profile
B
Borderline rifampicin mono-resistant TB treated with high-dose rifampicin.
E Commiesie, M Kamst, W C M de Lange, S Sewdien, S G S Vreden

Int J Tuberc Lung Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, treatment and transmission of rifampicin-resistant TB in the Netherlands, 2010-2019.
G de Vries, O Akkerman, M Boeree, R van Hest, M Kamst

Int J Tuberc Lung Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic Area.
R M Anthony, E Tagliani, V Nikolayevskyy, R de Zwaan, A Mulder, M Kamst

Microbiol Spectr· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
F A Gopie, E Commiesie, S Baldi, M Kamst, D Kaur

J Clin Tuberc Other Mycobact Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INNO-LiPA DNA line probe assay misidentification of M. smegmatis as Mycobacterium fortuitum complex.
Theo van den Broek, Nard G Janssen, David J Hetem, Wouter Bekers, Miranda Kamst

Diagn Microbiol Infect Dis· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis